                         SEQUENCE LISTING

<110>  DUKE UNIVERSITY
 
<120>  METHODS FOR TREATMENT OF CANCER USING ABL INHIBITORS AND DRUGS 
       TARGETING THE MEVALONATE PATHWAY

<130>  106707-1288837

<150>  63/134,991
<151>  2021-01-08

<160>  13    

<170>  PatentIn version 3.5

<210>  1
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic primer

<400>  1
gacctcaacg cacagtacga g                                                 21


<210>  2
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic primer

<400>  2
aggagtccca tgatgagatt gt                                                22


<210>  3
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic primer

<400>  3
ggtggggtca tgtgtgtgg                                                    19


<210>  4
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic primer

<400>  4
cggttcaggt actcagtcat cc                                                22


<210>  5
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic primer

<400>  5
gagctggtgg ttgactttct c                                                 21


<210>  6
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic primer

<400>  6
tccatctccg attcagtccc t                                                 21


<210>  7
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic primer

<400>  7
tgtgggcatc aatggatttg g                                                 21


<210>  8
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic primer

<400>  8
acaccatgta ttccgggtca at                                                22


<210>  9
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic shRNA

<400>  9
ggtgtatggg ctactataga a                                                 21


<210>  10
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic shRNA

<400>  10
ggtgtatgag ctgctagaga a                                                 21


<210>  11
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic shRNA

<400>  11
ccttatctca cccactctga a                                                 21


<210>  12
<211>  58
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic shRNA

<400>  12
ccgggcagtg ataaaggagg catttctcga gaaatgcctc ctttatcact gctttttg         58


<210>  13
<211>  58
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic shRNA

<400>  13
ccggcctgct gctataaatt ggatactcga gtatccaatt tatagcagca ggtttttg         58


